Luk Van Parijs, Alexander Ibraghimov, Abul K. Abbas  Immunity 

Slides:



Advertisements
Similar presentations
Volume 141, Issue 2, Pages e2 (August 2011)
Advertisements

Volume 7, Issue 5, Pages (November 1997)
Cheng-Ming Sun, Edith Deriaud, Claude Leclerc, Richard Lo-Man  Immunity 
Regulation of Mast Cell Survival by IgE
Impaired Responses of Peripheral Blood Mononuclear Cells to Staphylococcal Superantigen in Patients with Severe Atopic Dermatitis: A Role of T Cell Apoptosis 
Volume 26, Issue 3, Pages (March 2007)
Volume 15, Issue 1, Pages (July 2001)
Inhibition of Th1 Differentiation by IL-6 Is Mediated by SOCS1
Volume 31, Issue 2, Pages (August 2009)
The Roles of Fas/APO-1 (CD95) and TNF in Antigen-Induced Programmed Cell Death in T Cell Receptor Transgenic Mice  Huey-Kang Sytwu, Roland S Liblau, Hugh.
Biochemical Mechanisms of IL-2–Regulated Fas-Mediated T Cell Apoptosis
Volume 15, Issue 1, Pages (July 2001)
Volume 141, Issue 2, Pages e2 (August 2011)
Volume 30, Issue 4, Pages (April 2009)
Volume 18, Issue 5, Pages (May 2003)
Volume 32, Issue 5, Pages (May 2010)
Volume 140, Issue 7, Pages (June 2011)
Local Expression of TNFα in Neonatal NOD Mice Promotes Diabetes by Enhancing Presentation of Islet Antigens  E.Allison Green, Elizabeth E. Eynon, Richard.
Volume 29, Issue 1, Pages (July 2008)
Volume 6, Issue 4, Pages (April 1997)
Mark H Kaplan, Ulrike Schindler, Stephen T Smiley, Michael J Grusby 
NKT Cells Inhibit the Onset of Diabetes by Impairing the Development of Pathogenic T Cells Specific for Pancreatic β Cells  Lucie Beaudoin, Véronique.
Volume 6, Issue 5, Pages (May 1997)
Volume 25, Issue 1, Pages (January 2014)
Impaired Th2 Subset Development in the Absence of CD4
Volume 14, Issue 1, Pages (January 2001)
Down-Regulation of IL-4 Gene Transcription and Control of Th2 Cell Differentiation by a Mechanism Involving NFAT1  Alexander Kiani, João P.B Viola, Andrew.
A Two-Step Process for Thymic Regulatory T Cell Development
Regulation of Mast Cell Survival by IgE
Volume 15, Issue 1, Pages (July 2001)
Volume 29, Issue 6, Pages (December 2008)
Volume 33, Issue 4, Pages (October 2010)
Volume 32, Issue 5, Pages (May 2010)
T Cell–Mediated Elimination of B7.2 Transgenic B Cells
Volume 34, Issue 3, Pages (March 2011)
Ana Belén Blázquez, Lloyd Mayer, M. Cecilia Berin  Gastroenterology 
CD40, but Not CD40L, Is Required for the Optimal Priming of T Cells and Control of Aerosol M. tuberculosis Infection  Vanja Lazarevic, Amy J Myers, Charles.
Volume 29, Issue 1, Pages (July 2008)
CTLA-4 Regulates Induction of Anergy In Vivo
Volume 9, Issue 3, Pages (September 1998)
T Cells with Low Avidity for a Tissue-Restricted Antigen Routinely Evade Central and Peripheral Tolerance and Cause Autoimmunity  Dietmar Zehn, Michael.
Volume 5, Issue 1, Pages (July 1996)
Volume 16, Issue 4, Pages (April 2002)
In Vivo Expansion of Regulatory T cells With IL-2/IL-2 mAb Complexes Prevents Anti- factor VIII Immune Responses in Hemophilia A Mice Treated With Factor.
CD44 Regulates Survival and Memory Development in Th1 Cells
Volume 14, Issue 5, Pages (May 2001)
Antigen-Specific Suppression of a Primed Immune Response by Dendritic Cells Mediated by Regulatory T Cells Secreting Interleukin-10  Ela Martin, Brendan.
Volume 2, Issue 2, Pages (February 2008)
Volume 30, Issue 4, Pages (April 2009)
Interleukin-21 Inhibits Dendritic Cell-Mediated T Cell Activation and Induction of Contact Hypersensitivity In Vivo  Donald C. Foster, Ralf Paus  Journal.
Volume 28, Issue 5, Pages (May 2008)
Volume 87, Issue 2, Pages (October 1996)
Volume 7, Issue 3, Pages (September 1997)
A Function of Fas-Associated Death Domain Protein in Cell Cycle Progression Localized to a Single Amino Acid at Its C-Terminal Region  Zi Chun Hua, Sue.
Notch 1 Signaling Regulates Peripheral T Cell Activation
The CD28 Signaling Pathway Regulates Glucose Metabolism
Toll-Dependent Control Mechanisms of CD4 T Cell Activation
Volume 25, Issue 12, Pages e5 (December 2018)
Volume 9, Issue 3, Pages (September 1998)
Interleukin-10-Treated Dendritic Cells Modulate Immune Responses of Naive and Sensitized T Cells In Vivo  Gabriele Müller, Anke Müller  Journal of Investigative.
Volume 9, Issue 5, Pages (November 1998)
Volume 28, Issue 1, Pages (January 2008)
Volume 32, Issue 5, Pages (May 2010)
Volume 13, Issue 11, Pages (December 2015)
Thymocyte Glucocorticoid Resistance Alters Positive Selection and Inhibits Autoimmunity and Lymphoproliferative Disease in MRL-lpr/lprMice  Eva Tolosa,
Volume 4, Issue 5, Pages (May 1996)
Volume 7, Issue 4, Pages (October 1997)
Volume 25, Issue 3, Pages (September 2006)
Volume 20, Issue 6, Pages (June 2004)
Volume 10, Issue 3, Pages (March 1999)
Presentation transcript:

The Roles of Costimulation and Fas in T Cell Apoptosis and Peripheral Tolerance  Luk Van Parijs, Alexander Ibraghimov, Abul K. Abbas  Immunity  Volume 4, Issue 3, Pages 321-328 (March 1996) DOI: 10.1016/S1074-7613(00)80440-9

Figure 1 In Vitro Activation of Wild-Type and Fas-Deficient T Cells in the Presence of Competent APCs Can Be Blocked with mCTLA-4Ig Naive CD4+ T cells (a) or Th1 lines (b) derived from wild-type and lpr/lpr 2B4 mice were cultured in triplicate with PCC (81–104) peptide in the presence of mitomycin C-treated H-2k spleen cells, alone, or with 2 μg/ml mCTLA-4Ig or control immunoglobulin. Proliferation was assessed by [3H]thymidine incorporation at 72 hr (a) or 36 hr (b). The error bars represent standard errors. Immunity 1996 4, 321-328DOI: (10.1016/S1074-7613(00)80440-9)

Figure 2 In Vitro Activation of Wild-Type and Fas-Deficient T Cells in the Presence of PAF APCs Requires a CD28-Mediated Signal Naive CD4+ T cells (a) or Th1 lines (b) derived from wild-type and lpr/lpr 2B4 mice were cultured in triplicate with PCC (81–104) peptide in the presence of PAF H-2k spleen cells, alone, or with anti-CD28 or control antibody (1:1000 dilution of hybridoma ascites). Proliferation was assessed by [3H]thymidine incorporation at 72 hr (a) or 48 hr (b). The error bars represent standard errors. Immunity 1996 4, 321-328DOI: (10.1016/S1074-7613(00)80440-9)

Figure 3 PCD in Naive T Cells Is Regulated by Costimulation and Not by Fas Naive CD4+ T cells derived from wild-type and lpr/lpr 2B4 mice were cultured in duplicate (a) with or without PCC (81–104) peptide in the presence of mitomycin C-treated H-2k spleen cells, alone, or with 2 μg/ml mCTLA-4Ig or control immunoglobulin, or (b) with increasing concentrations of soluble anti-CD3, together with anti-CD28 or control antibody (1:1000 dilution of hybridoma ascites). After 48 hr, cell death was assessed by double staining for the transgenic TCR (recognized by the A2B4 monoclonal antibody) and propidium iodide incorporation. The error bars represent standard errors. Immunity 1996 4, 321-328DOI: (10.1016/S1074-7613(00)80440-9)

Figure 4 AICD in Activated T Cells Is Regulated by Fas and Not by Costimulation Wild-type and lpr/lpr 2B4 Th1 lines were generated as described and cultured in duplicate in medium containing 20 U/ml IL-2 (a) with or without immobilized anti-CD3 (1 μg/ml) and anti-CD28 (1:1000 dilution of hybridoma ascites), 2 μg/ml mCTLA-4Ig, or control immunoglobulin, or (b) with increasing concentrations of soluble anti-CD3, together with anti-CD28 or control antibody. After 24 hr, cell death was assessed by double staining for the transgenic TCR (recognized by the A2B4 monoclonal antibody) and propidium iodide incorporation. The error bars represent standard errors. Immunity 1996 4, 321-328DOI: (10.1016/S1074-7613(00)80440-9)

Figure 5 bcl-xL and FasL mRNA Induction Differs in CD28 Dependence and in Its Correlation with Different Forms of Cell Death The expression of bcl-xL and FasL mRNA in naive or activated Th1 2B4/+ T cells was assayed by RT–PCR following a 24 hr culture with or without soluble anti-CD3 (1 μg/ml) and anti-CD28 (1:1000 dilution of hybridoma ascites). The percentage of apoptotic 2B4/+ T cells in parallel cultures was assessed either at 24 hr (2B4 Th1 line) or 48 hr (naive 2B4 T cells) and gave the following results: naive 2B4 T cells: media, 38%; anti-CD3, 32%; anti-CD3/anti-CD28, 7%; 2B4 Th1 line: media, 27%; anti-CD3, 45%; anti-CD3/anti-CD28, 52%. Immunity 1996 4, 321-328DOI: (10.1016/S1074-7613(00)80440-9)

Figure 6 Superantigen-Mediated Deletion Is Defective in the Periphery, but Not the Thymus, of Fas-Deficient Mice Wild-type and lpr mice were treated intraperitoneally with 2 μg SEB on days 1, 3, and 5. On day 8, the percentage of Vβ8+ and Vβ6+ CD4+ T cells was assessed in the spleen (a) and the thymus (b) by two- or three-color flow cytometry. Data from two mice was pooled for each treatment, and the error bars represent the standard error. Results are from one representative experiment out of four. Immunity 1996 4, 321-328DOI: (10.1016/S1074-7613(00)80440-9)

Figure 7 Peripheral Unresponsiveness Can Be Induced in Fas-Deficient Mice MRL +/+ (a) and lpr/lpr (b) mice were treated intraperitoneally with 1 mg OVA, emulsified in IFA. The mice were challenged 10 days later by injecting 200 μg OVA, emulsified in CFA, into the footpad. On day 20, the inguinal and popliteal lymph nodes were harvested, and the lymph node cells restimulated in vitro with OVA, as shown. Proliferation was assessed at 72 hr. Cytokine production was assessed at 48 hr for IL-2 or 72 hr for IL-4 and IFNγ. Data were pooled from 2–4 mice per group, and the error bars represent the standard error. Results are from one representative experiment out of four. Immunity 1996 4, 321-328DOI: (10.1016/S1074-7613(00)80440-9)